Related Experiment Video
Updated: Jul 4, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal function
Barbora Agatha Halouzková1, Michaela Jelínková1,2, Jan Miroslav Hartinger1
1Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Background:
Tiapride is widely used for the treatment of confusion in the elderly and for other indications. Kidney impairment is common in the elderly population and may influence tiapride pharmacokinetics. However, pharmacokinetic alterations of tiapride in patients with kidney disease have not been described so far.
Methods:
We studied tiapride pharmacokinetics in 71 predominantly elderly patients with various degrees of kidney impairment, including patients receiving hemodialysis. A population pharmacokinetic model and Monte Carlo simulations were used to evaluate tiapride exposure and optimize dosing across different degrees of renal impairment.
Results:
Tiapride pharmacokinetics was strongly dependent on renal function, while other tested covariates had no significant effect. Drug exposure was approximately fivefold higher in patients with severe kidney impairment, indicating the need for substantial dose reduction to prevent overdose. The model enabled development of dosing recommendations for patients with CKD, including those receiving hemodialysis. Due to prolonged elimination in advanced CKD, drug effects may persist for several days after discontinuation.
Conclusion:
Renal function is the key determinant of tiapride pharmacokinetics. These findings provide practical dosing recommendations for elderly patients with kidney impairment and may improve the safety of tiapride therapy in clinical practice.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion